Long‐term follow‐up of children with risk organ‐negative Langerhans cell histiocytosis after 2‐chlorodeoxyadenosine treatment-Reference-Cited by-同舟云学术

Long‐term follow‐up of children with risk organ‐negative Langerhans cell histiocytosis after 2‐chlorodeoxyadenosine treatment

Published:2020-07-22 Issue:5 Volume:191 Page:825-834
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br. J. Haematol.

Author:

Barkaoui Mohamed‐Aziz¹,Queheille Emma¹,Aladjidi Nathalie²^ORCID,Plat Geneviève³,Jeziorski Eric⁴,Moshous Despina⁵⁶,Lambilliotte Anne⁷,Kebaili Kamila⁸,Pacquement Hélène⁹,Leverger Guy¹⁰,Mansuy Ludovic¹¹,Entz‐Werlé Natacha¹²,Bodet Damien¹³,Schneider Pascale¹⁴,Pagnier Anne¹⁵,Lutun Anne¹⁶,Gillibert‐Yvert Marion¹⁷,Millot Fréderic¹⁸,Toutain Fabienne¹⁹,Reguerre Yves²⁰,Thomas Caroline²¹,Tazi Abdelatif²²²³,Emile Jean‐François²⁴,Donadieu Jean¹¹⁰^ORCID,Héritier Sébastien¹¹⁰²⁴^ORCID

Affiliation:

1. French Reference Center for Langerhans Cell HistiocytosisTrousseau Hospital Paris France

2. Department of Pediatric Hematology and Oncology Centre Hospitalo‐Universitaire de Bordeaux Bordeaux France

3. Department of Pediatric Hematology and Oncology Centre Hospitalo‐Universitaire de Toulouse Toulouse France

4. Department of Paediatric Hôpital Arnaud de VilleneuveCentre Hospitalo‐Universitaire de Montpellier Montpellier France

5. Department of Pediatric Immunology, Hematology and Rheumatology Necker HospitalAssistance Publique–Hôpitaux de Paris Paris France

6. Institut Imagine Paris UniversitySorbonne‐Paris‐Cité Paris France

7. Department of Pediatric Hematology and Oncology Centre Hospitalo‐Universitaire de Lille Lille France

8. Department of Paediatric Oncology Institut d'Hémato‐Oncologie Pediatrique Lyon France

9. Pediatric, Adolescent and Young Adult Oncology Department Institut Curie Medical Center Paris France

10. Department of Pediatric Hematology and Oncology Faculté de médecine, Trousseau Hospital Sorbonne UniversitéAssistance Publique–Hôpitaux de Paris Paris France

11. Department of Pediatric Hematology and Oncology Centre Hospitalo‐Universitaire de Nancy Vandœuvre‐lès‐Nancy France

12. Department of Pediatric Hematology and Oncology Centre Hospitalo‐Universitaire de Strasbourg Strasbourg France

13. Department of Pediatric Hematology and Oncology Centre Hospitalo‐Universitaire de Cean Cean France

14. Department of Pediatric Hematology and Oncology Centre Hospitalo‐Universitaire de Rouen Rouen France

15. Department of Pediatric Hematology and Oncology Centre Hospitalo‐Universitaire de Grenoble Grenoble France

16. Department of Pediatric Hematology and Oncology Centre Hospitalo‐Universitaire d'Amiens Amiens France

17. Department of Pediatric Hematology and Oncology Centre Hospitalo‐Universitaire de Tours Tours France

18. Department of Pediatric Hematology and Oncology Centre Hospitalo‐Universitaire de Poitiers Poitiers France

19. Department of Pediatric Hematology and Oncology Centre Hospitalo‐Universitaire de Rennes Rennes France

20. Department of Pediatric Hematology and Oncology Centre Hospitalo‐Universitaire Saint Denis de la Réunion St Denis France

21. Department of Pediatric Hematology and Oncology Centre Hospitalo‐Universitaire de Nantes Nantes France

22. Pneumology Department Saint‐Louis HospitalAssistance Publique–Hôpitaux de Paris Paris France

23. Université de ParisINSERM U976 Paris France

24. EA4340UVSQUniversité Paris‐Saclay Boulogne‐Billancourt France

Funder

Association la Petite Maison dans la Prairie

Association Histiocytose France

Institut de Veille Sanitaire

Institut National de la Santé et de la Recherche Médicale

Roche

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.16944

Reference34 articles.

1. Progress in understanding the pathogenesis of Langerhans cell histiocytosis: back to Histiocytosis X?

2. Recurrent BRAF mutations in Langerhans cell histiocytosis

3. Langerhans cell histiocytosis (LCH): Guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 years

4. BRAF Mutation Correlates With High-Risk Langerhans Cell Histiocytosis and Increased Resistance to First-Line Therapy

5. Cladribine and cytarabine in refractory multisystem Langerhans cell histiocytosis: results of an international phase 2 study

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Histiocitosis de células de Langerhans;EMC - Pediatría;2024-06

2. Dural involvement in central nervous system langerhans cells histiocytosis (LCH) on FDG PET/CT: Case report and review of CNS manifestations of LCH on PET/CT;Radiology Case Reports;2024-04

3. Adult localized Langerhans cell histiocytosis: A case report;World Journal of Clinical Cases;2023-12-06

4. Therapiestrategien bei Kindern und Jugendlichen mit Langerhanszell Histiozytosen;Klinische Pädiatrie;2023-09-06

5. Molecular and clinicopathologic characterization of pediatric histiocytoses;American Journal of Hematology;2023-04-28